Registered Owners
- View profile →
ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
NPWP: 12345678910
owner
Direktorat Registrasi ObatValid
PACLITAXEL
- BPOM Number
- GKL2257900743A1
- Approved
- 21 July 2026
- Expiry
- 21 July 2031
- Form
- INJEKSI
About This Registration
PACLITAXEL is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2257900743A1. Its current registration status is Valid, with the licence valid until 21 July 2031. The product is registered to ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA. BPOM first approved this registration in July 2026. All registration data is sourced directly from the official BPOM public database and updated daily.
Registration data updated by BPOM
This product's registration details were changed on 22 July 2026. This may reflect a status change, renewal, or correction by BPOM.
Registration Details
- Application
- newaero
- Packaging
- DUS, 1 VIAL @ 5 ML
- Department
- Direktorat Registrasi Obat
- Data Last Updated
- 22 July 2026
Retail Audit Service
Get detailed market intelligence for this product across Indonesian retail channels
Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?
Stock availability and positioning verification
Price checking and competitor analysis
Display quality and promotional material assessment
Store condition and customer experience evaluation
Custom questions tailored to your research needs
Professional photographs and detailed reports
Manufacturing Sites
- View profile →
ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
primary
Ingredients (1)
PACLITAXEL
Market Intelligence
- Owner Portfolio
- ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA holds 70 BPOM registrations
- Manufacturer Scale
- ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA produces 70 registered products
- Registration Age
- Registered for 2 months
- Update Status
- Recently updated (64 days ago)
FDA Cross-Reference
via openFDA- Generic Name
- PACLITAXEL
- Product Type
- HUMAN PRESCRIPTION DRUG
- Route of Administration
- INTRAVENOUS
Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.
Is this your product?
Claim it to manage registration, track renewals, and get expiry alerts.